ArticleAdvances in rheumatology (London, England)2023

Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases.

Manuel Pombo-Suárez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.